8-KEarnings & ResultsExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Financial Results (May 5, 2016)

Filed May 5, 2016For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on May 5, 2016, primarily to furnish a press release detailing its financial and operating results for the first quarter ended March 31, 2016. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for this crucial information. Investors should review this press release to understand the company's performance, including revenue, profitability, and key operational metrics for the period. The filing serves as a formal notification of the release of quarterly results. The information contained in the press release, while significant for understanding REGN's current business performance and future outlook, is specifically noted as not being "filed" for purposes of Section 18 of the Securities Exchange Act, meaning it does not carry the same legal implications as formally filed documents unless expressly incorporated into another filing.

Key Highlights

  • 1REGN filed an 8-K on May 5, 2016, to report Q1 2016 financial and operating results.
  • 2The key financial details are contained within a press release furnished as Exhibit 99.1.
  • 3Investors need to consult Exhibit 99.1 for specific performance data.
  • 4The filing covers the quarter ended March 31, 2016.
  • 5Information furnished in this 8-K is not deemed "filed" under Section 18 of the Exchange Act unless explicitly incorporated by reference.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally report Regeneron Pharmaceuticals, Inc.'s financial and operating results for the first quarter ended March 31, 2016, by furnishing a press release that contains these details.

The detailed financial and operating results for the first quarter ended March 31, 2016, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

No, the 8-K filing itself does not contain the specific financial numbers. It refers investors to the press release (Exhibit 99.1) for the detailed Q1 2016 financial and operating results.

The disclaimer means that the information provided in this specific filing (and its attached press release) is considered 'furnished' rather than 'filed' under Section 18 of the Securities Exchange Act of 1934. This has implications for liability under that specific section, although the information is still crucial for investors to understand company performance.